proteomics Latest News

NuGel-Hemoglobind™ is developed specifically for hemoglobin removal from whole blood and hemolyzed serum for biomarker and drug discovery applications.

The patent cites Cleanascite™ from Biotech Support Group in a method for the selection of neutralizing antibodies to mouse IL-17F and IL-17A.

The patent cites BindPro™ from Biotech Support Group and details a method for measuring interstitial fluid glucose concentration via ion chromatography.

United States Patent Application 20120107841 titled, “Serum Diagnostic Method, Biomarker and Kit for Early Detection and Staging of Alzheimer's Disease” cites Cleanascite™ from Biotech Support Group for lipid clarification

Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification

UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples

RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities.

A 2-day Symposium on "Cloud Computing: Applications and Advances in Life Sciences R&D" will take place on Feb. 19-20, 2012 at the InterContinental Hotel, San Francisco. This symposium is part of many offerings at the Molecular Med TRI-CON 2012.

Seattle, WA, 27 September, 2011 - Dilyx Biotechnologies, LLC announces the launch of the OptiResc Protein Aggregate Solubilization Kit, allowing research scientists to rescue inadvertently aggregated protein samples. ¬

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

Article published in Vascular Proteomics titled, "Characterization of membrane and cytosolic proteins of erythrocytes"

NuGel-Hemoglobind™ is developed specifically for hemoglobin removal from whole blood and hemolyzed serum for biomarker and drug discovery applications.

The patent cites Cleanascite™ from Biotech Support Group in a method for the selection of neutralizing antibodies to mouse IL-17F and IL-17A.

The patent cites BindPro™ from Biotech Support Group and details a method for measuring interstitial fluid glucose concentration via ion chromatography.

Researchers used AlbuVoid™ for serum albumin depletion for secretome sample preparation. Albumin was depleted from cell culture in serum containing medium using AlbuVoid™ to isolate and identify low abundance proteins.

HemoVoid™ Blood Card is developed for the purification & enrichment of hemoglobin from blood for hemoglobin variant research. It is compatible with protocols which require direct surface sampling of dried blood spot (DBS) to identify proteins.

United States Patent Application 20120107841 titled, “Serum Diagnostic Method, Biomarker and Kit for Early Detection and Staging of Alzheimer's Disease” cites Cleanascite™ from Biotech Support Group for lipid clarification

Cleanascite™ is an ideal sample clarification and purification reagent for physicochemical fractionation antibody purification, class-specific affinity purification of antibodies, antigen-specific affinity purification of antibodies.

AlbuSorb™ from Biotech Support Group for albumin depletion from synovial fluid samples to comparatively find and analyze novel biomarkers of rheumatoid arthritis of disease and non disease patient samples by proteomic techniques.

ProCipitate™ is high throughput, high yield, and cost efficient for small or large sample genomic DNA enrichment. It is compatible with high throughput genomic DNA isolation and produces high quality DNA over alternative bind and elute systems.

Cleanascite™ from Biotech Support Group cleans up samples and it extends the life of membrane and chromatographic columns for large scale monoclonal antibody purification

UPCK™ Urine Protein Enrichment/Concentration Kit features a urinary protein enrichment optimized protocol for sample preparation and downstream analysis of urine samples

NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins.

Hemoglobin Depletion Plus Protein Enrichment From Dried Blood Spot (Blood Card) Technology

Signup to attend protein enrichment webinar series to explore proteomics and genomic sample preparation products and research featuring albumin depletion, urine protein enrichment, glycoproteins enrichment.

Cleanascite™ for lipid removal and identification of biomarkers for environmental contamination from fish bile samples containing metalloproteinases

The field of disease proteomics has, until recently, focused on separation techniques coupled with mass-spectrometric identification of proteins, reports Genetic Engineering & Biotechnology News (GEN).

Seattle, WA, - Dilyx Biotechnologies, LLC is pleased to announce that is has signed an agreement with Funakoshi Co. Ltd. of Japan, to distribute Dilyx’ protein solubility products in that region.

BioDatomics is a software/hardware platform supported by cutting edge data storage & delivery technologies and can deliver all the computational power required for high throughput techniques in the discovery of disease treatment, origin & prevention.

RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities.

A 2-day Symposium on "Cloud Computing: Applications and Advances in Life Sciences R&D" will take place on Feb. 19-20, 2012 at the InterContinental Hotel, San Francisco. This symposium is part of many offerings at the Molecular Med TRI-CON 2012.

Seattle, WA, 27 September, 2011 - Dilyx Biotechnologies, LLC announces the launch of the OptiResc Protein Aggregate Solubilization Kit, allowing research scientists to rescue inadvertently aggregated protein samples. ¬

Innovation in the design of vaccines is rapidly expanding their use, safety, and effectiveness for disease prevention and therapeutic interventionsis examined in a special issue of OMICS: A Journal of Integrative Biology .

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

A new automated sample preparation system based on Tecan’s Freedom EVO® 200 liquid handling platform has been developed for proteomic biomarker discovery and validation in collaboration with the Translational Genomics Research Institute (TGen)

Norton Scientific, responding to the needs of the global research community, is proud to announce that the company has launched a new applications support service targeting the field of proteomics.

A University of Victoria researcher hopes to change the nature of testing for heart disease, cancer and drug toxicity using a highly sensitive and fast machine that would only require a single drop of blood from a patient.

Fast market research recommends "top 10 drug discovery technologies - strategic analysis and global forecasts" from markets and markets, now available

UCB seeking to understand cell signalling mechanisms of therapeutic antibodies enabling identification of biomarkers

RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011 and will accept applications for restricted pilot grants of $5,000 to $20,000 worth of RayBiotech products and/or services beginning in early 2011.

Ubiquitin Conference 2010 is a Meeting of Minds from Industry and Academia

Ubiquitin Conference 2010 is a Meeting of Minds from Industry and Academia

ProteoIQ 2.0 provides researchers with a unified software solution for the major proteomic quantification strategies and adds tools for distilling biological meaning from high-throughput proteomic data in a manner that was not previously possible.

Recently published research from Business Insights, "Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook", is now available at Fast Market Research

International business consultancy group, Bridge4Bio employs its ten-strong global consultant network to help life sciences and biotechnology companies progress their business growth plans faster, more efficiently and at a lower cost

Proteome Solutions will be exhibiting at the 6th annual US Hupo 2010 conference in Denver Colorado March 7-10. Stop by our booth #4 to see the latest ProteinID Finder and meet our staff.

Bridge4Bio, an international business consultancy group focused on promoting the growth of life sciences and biotech companies, is targeting 4 strategic areas to assist both startups and established companies plan and grow their businesses globally.

ProteinID Finder is a proteomics analyzation software capable of extracting information from the online universal protein resource database UniProt. The release of v1.8 adds new powerful graphing capabilities to Proteome Solutions ProteinID Finder.

Hudson Robotics, Inc. today introduced the new VaryScreen™ ADME-Tox integrated workstation for faster, accurate and more efficient profiling of the absorption, distribution, metabolism and excretion (ADME) properties of drug molecules.

Proteome Solutions today announces the availability of ProteinID Finder version 1.7.0 (v1.7.0). ProteinID Finder is a proteomics analyzation software capable of extracting information from the online universal protein resource database UniProt.

BioInquire, LLC is awarded a Phase II Small Business Technology Transfer (STTR) grant totaling $747K. The grant, entitled Development of Software for Comparative and Quantitative Clinical Proteomics, was awarded by the National Institute of Health.

RayBiotech today announced the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services for protein biomarker discovery.

New protein discovery gives chronic diarrhea patients hope. Many have been told it is all in their head, but this new research target may lead to help. Functional indicators and patient correlation are reasons for optimism.